Vesely Stepan, Knutson Tomas, Damber Jan-Erik, Dicuio Mauro, Dahlstrand Christer
Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden.
Neurourol Urodyn. 2006;25(7):770-5. doi: 10.1002/nau.20233.
To evaluate the long-term outcome of transurethral resection of the prostate (TURP) and transurethral microwave thermotherapy (TUMT) in men with symptomatic benign prostatic hyperplasia (BPH), when allocation to the treatment-group was based on urodynamic diagnosis of bladder outlet obstruction (BOO).
A total of 231 elderly men with symptomatic BPH were treated either by TURP or by low-energy TUMT. A pressure-flow study was performed to detect the obstruction and to help in the selection of the two treatments. The patients were examined at baseline then checked again after 2 and 8 years.
At 2 years of follow-up there was a significant improvement for both IPSS and QoL (P < 0.0001) in both groups of treatment. This was accompanied by a significant improvement (P < 0.0001) in the maximum flow rate from 10.0 (5.8) to 16.4 (7.6) in the TURP group and from 12.1 (5.2) to 14.9 (5.7) in the TUMT group. These findings persisted at 8 years, they were, however, more pronounced after TURP. The overall retreatment rate reached a value of 11% in the TURP group and 27% in the TUMT group, respectively. At the follow-up, 95% of the patients who underwent TURP and 70% of the patients treated by TUMT claimed to be satisfied with that choice.
With durable symptomatic improvement and lowest retreatment rate, TURP still presents a standard treatment option for patients with severe BOO. Low-energy TUMT has sufficiently relieved patients' symptoms and can be offered to less obstructed patients as an alternative.
评估经尿道前列腺切除术(TURP)和经尿道微波热疗(TUMT)对有症状的良性前列腺增生(BPH)男性患者的长期疗效,其中治疗组的分配基于膀胱出口梗阻(BOO)的尿动力学诊断。
共有231名有症状的老年BPH男性患者接受了TURP或低能量TUMT治疗。进行压力-流率研究以检测梗阻情况并辅助两种治疗方法的选择。患者在基线时接受检查,然后在2年和8年后再次检查。
在2年随访时,两组治疗的国际前列腺症状评分(IPSS)和生活质量(QoL)均有显著改善(P<0.0001)。同时,TURP组的最大尿流率从10.0(5.8)显著提高到16.4(7.6),TUMT组从12.1(5.2)提高到14.9(5.7)(P<0.0001)。这些结果在8年时仍然存在,不过在TURP后更为明显。TURP组和TUMT组的总体再次治疗率分别达到11%和27%。在随访中,95%接受TURP的患者和70%接受TUMT治疗的患者声称对该选择感到满意。
TURP具有持久的症状改善效果和最低的再次治疗率,仍然是重度BOO患者的标准治疗选择。低能量TUMT已充分缓解了患者的症状,可作为梗阻较轻患者的替代选择。